An integrated transcriptomic and epigenomic analysis identifies CD44 gene as a potential biomarker for weight loss within an energy-restricted program

Respuesta :

An integrated transcriptomic and epigenomic analysis identifies the CD44 gene as a potential biomarker for weight loss within an energy-restricted program: TRUE

What is an integrated transcriptomic and epigenomic analysis?

  • Because of the interindividual variability in response to weight-loss treatments, new predictive biomarkers are needed to improve the efficacy of weight-loss programs.
  • The goal of this work is to find new genes that distinguish individual responses to a weight-loss dietary regimen by combining mRNA expression and DNA methylation arrays.
  • Different expression and DNA methylation profiles were found in LR versus HR.
  • The integrative analysis of the array data found four genes that were differentially methylated and expressed between groups: CD44, ITPR1, MTSS1, and FBXW5.
  • In LR, CD44 expression was higher and DNA methylation levels were lower than in HR.

Therefore, the statement "an integrated transcriptomic and epigenomic analysis identifies the CD44 gene as a potential biomarker for weight loss within an energy-restricted program" is TRUE.

Know more about weight loss here:

https://brainly.com/question/1519447

#SPJ4

Complete question:

An integrated transcriptomic and epigenomic analysis identifies the CD44 gene as a potential biomarker for weight loss within an energy-restricted program. TRUE or FALSE